BioPlx
Boulder, US · Founded 2015 · Colorado corporation
Founders & leadership
RS
Ravi StarzlNamed on SEC filing
TS
Timothy StarzlNamed on SEC filing
BS
Bimla StarzlNamed on SEC filing
NS
Norman Stuart HarrisNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 2 rounds · 2019–2020
▶$1.1MraisedFeb 2020 · 2 investors · BiotechnologyRule 506(b)
▶$1.1MraisedFeb 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ravi StarzlExecutive Officer, Director
- Norman Stuart HarrisDirector
- Timothy StarzlExecutive Officer, Director
- Bimla StarzlExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.1M
- Minimum investment
- $100K
- First sale
- Feb 2020
- Incorporated
- Corporation, Colorado, 2015
- Federal exemptions
- 06b
▶$1.6MraisedAug 2019 · 12 investors · BiotechnologyRule 506(c)
▶$1.6MraisedAug 2019 · 12 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Ravi StarzlExecutive Officer, Director
- Timothy StarzlExecutive Officer, Director
- Bimla StarzlExecutive Officer, Director
- Norman Stuart HarrisDirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Jun 2019
- Incorporated
- Corporation, Colorado, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has BioPlx raised?
- BioPlx has disclosed $2.7M raised across 2 rounds.
- Where is BioPlx headquartered?
- BioPlx is headquartered in Boulder, US.